Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
MTOR Inhibitor
100%
Antitumor Activity in Vitro
100%
Downstream Signaling
33%
Cell Proliferation
16%
Antitumor Activity
16%
Signaling Pathway
16%
Phosphoinositide 3-kinase (PI3K)
16%
Cancer Therapy
16%
Cell Survival
16%
Phosphorylation
16%
In Vitro Study
16%
Commercially Available
16%
Signaling Molecules
16%
Lung Tumor
16%
Kinase Activity
16%
Intraperitoneal Injection
16%
Tumor-bearing Mice
16%
Growth Inhibition
16%
Dose Effect
16%
Tumor Tissue
16%
P70S6K
16%
Non-small Cell Lung Cancer Cells
16%
Benzo
16%
Cancer Types
16%
G1 Cell Cycle Arrest
16%
A549
16%
Docking Technique
16%
MTOR Pathway
16%
Ligand Docking
16%
Indolin-3-ones
16%
Kinase Protein
16%
Cancer Growth
16%
Homologous Structure
16%
Novel Scaffolds
16%
Natural Product Library
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antitumor Activity
100%
Mammalian Target of Rapamycin Inhibitor
100%
Malignant Neoplasm
66%
Mammalian Target of Rapamycin
66%
Lung Tumor
33%
Non Small Cell Lung Cancer
33%
Natural Product
33%
Cancer Growth
33%
Phosphatidylinositol 3 Kinase
33%
Intraperitoneal Injection
33%
Neoplasm
33%